XML 31 R12.htm IDEA: XBRL DOCUMENT v3.6.0.2
Research and Development and Government and Industry Funded Contracts
12 Months Ended
Dec. 31, 2016
Government and Industry Funded Contracts [Abstract]  
Research and Development and Government and Industry Funded Contracts
Research and Development and Government and Industry Funded Contracts
The Company has invested directly in multiple emerging technologies, such as power generation data analytics, technologies aimed at the separation, capture and control of CO2 emissions related to power generation, natural gas small scale liquefaction technologies and energy storage applications through and research and development activities supported by contracts with the DOE and industry participants. The contracts with the DOE can take the form of grants or cooperative agreements and are considered financial assistance awards. The deliverables required by the DOE agreements include various technical and financial reports that the Company submits on a prescribed schedule. The agreements require the Company to perform the negotiated scope of work in agreed phases, which includes testing and demonstration of technologies.
The Company has participated in several contracts awarded by the DOE. The Company typically invoices the DOE and industry cost-share partners monthly for labor and expenditures plus estimated overhead factors, less any cost share amounts. The contracts under which the Company has performed are subject to audit, the result of which may require the Company to reimburse the DOE for disallowed costs and other adjustments. The Company has not experienced any material adverse adjustments as a result of completed government audits. However, the government audits for years ended 2010 through 2015 have not yet been finalized. The following table shows the impact to Research and development expense amounts recognized in the Consolidated Statement of Operations:
 
 
Years Ended December 31,
(in thousands)
 
2016
 
2015
 
2014
Research and development expense
 
$
173

 
$
6,737

 
$
3,554

Less:
 
 
 
 
 
 
DOE funding
 
821

 
1,375

 
1,756

Industry cost-share funding
 

 

 
277

Research and development expense, net
 
$
(648
)
 
$
5,362

 
$
1,521



Included within the above research and development expenses during 2015 is net impairment expense of $1.9 million for the entire carrying value of the Company's ADA Analytics' assets, as discussed in Note 2 and Note 8.